Literature DB >> 6500901

Failure of carbamazepine to prevent clonazepam withdrawal status epilepticus.

G P Sechi, G Zoroddu, G Rosati.   

Abstract

We describe two patients in whom clonazepam withdrawal status epilepticus occurred in spite of therapeutic levels of carbamazepine in plasma and cerebrospinal fluid. The failure of carbamazepine to prevent clonazepam withdrawal status epilepticus is discussed.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6500901     DOI： 10.1007/bf02043959

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN： 0392-0461


  7 in total

1.  The prevention of ethanol withdrawal seizures in rats by dipropylacetate.

Authors:  M E Hillbom
Journal:  Neuropharmacology       Date:  1975-10       Impact factor: 5.250

2.  Prevention of febrile convulsions with dipropylacetate (Depakine).

Authors:  G B Cavazzuti
Journal:  Epilepsia       Date:  1975-11       Impact factor: 5.864

3.  CSF concentrations and serum protein binding of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients.

Authors:  S I Johannessen; M Gerna; J Bakke; R E Strandjord; P L Morselli
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

4.  Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal multicentre doubl-blind comparison with placebo.

Authors:  S E Björkqvist; M Isohanni; R Mäkelä; L Malinen
Journal:  Acta Psychiatr Scand       Date:  1976-05       Impact factor: 6.392

5.  Side effects of clonazepam therapy.

Authors:  V E Edwards
Journal:  Proc Aust Assoc Neurol       Date:  1974

6.  Clonazepam in a focal-motor monkey model: efficacy, tolerance, toxicity, withdrawal, and management.

Authors:  J S Lockard; R H Levy; W C Congdon; L L DuCharme; L D Salonen
Journal:  Epilepsia       Date:  1979-12       Impact factor: 5.864

7.  Carbamazepine: prevention of alcohol withdrawal seizures.

Authors:  N S Chu
Journal:  Neurology       Date:  1979-10       Impact factor: 9.910
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.